BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact

denovoMATRIX Launches Novel Microcarrier to Advance Cell and Gene Therapy Manufacturing

May 4, 2022 By Cade Hildreth (CEO) Leave a Comment

beadMATRIX MSC-based therapies
DRESDEN, Germany, May. 04, 2022 — denovoMATRIX GmbH, an innovator in cell and gene therapy (CGT) manufacturing, announced the launch of a novel microcarrier for increasing access to high-quality mesenchymal stromal cells (MSCs) for stem cell-based therapies. The product, termed beadMATRIX, is designed to enable MSC proliferation and harvest in xeno-/serum-free media with high efficiency and stemness.

[Read more…]

Filed Under: Cell Therapy, MSCs, Press Releases, Stem Cell News, Stem Cells

How Human iPSCs are Revolutionizing Drug Discovery in 2022

May 3, 2022 By Cade Hildreth (CEO) Leave a Comment

ipsc drug discovery

Drug discovery involves high cost and uncertain outcomes.  Only a few companies can take the risk of investing enormous amounts of money into research and testing, only to see undesirable side effects emerge during the final human clinical trials. In many cases, companies are spending millions of dollars to fail during clinical testing.

Now, some new medicines are being tested for safety on specialized cells developed from human pluripotent cell lines. Cell types which are frequently being using within drug discovery applications include heart (cardiomyocytes) and liver cells (hepatocytes), which are the organs where 80% of drug failures occur. [Read more…]

Filed Under: iPS Cells Tagged With: drug discovery

Cell Therapy Manufacturing | Factors Driving Interest in Cell Therapy CDMOs

May 2, 2022 By Cade Hildreth (CEO) Leave a Comment

Cell Therapy CMO CDMO

Cell therapy manufacturing is becoming of growing importance as more and more cell therapeutics make their way through clinical trials. One of the major issues with moving cell therapy products from “bench to bedside” has been manufacturing bottlenecks. The heterogeneous nature of cell therapy products has introduced manufacturing complexity and regulatory concerns, as well as scale-up complexities that are not present within traditional pharmaceutical manufacturing.

Cell Therapy Manufacturing CDMOs

While these realities may sound like negative factors for the industry, the reality is quite the opposite. For cell therapy CDMOs, these factors create pressures for cell therapy companies to seek third-party partners who possess technical, manufacturing, and regulatory expertise in cell therapy development and manufacturing. [Read more…]

Filed Under: Stem Cells Tagged With: CDMO, cell therapy

Can We Extend the Human Lifespan With Regenerative Medicine?

May 1, 2022 By Cade Hildreth (CEO) 3 Comments

Regenerative Medicine

Regenerative medicine is a fascinating topic, because it requires you to ask yourself: Would you want to live to be 200 years old? A scientist from Stanford University thinks that it’s possible – so much so that he has placed a bet that there is someone alive today who will live to be 200 years old.

Over recent decades, modern scientific developments have led to a dramatic increase in human lifespan. But how much further can we go? Does regenerative medicine have the power to enable us all to live for many more years?

Let’s dive into this fascinating topic and find out more about regenerative medicine. How could it extend human life into the future? [Read more…]

Filed Under: Stem Cells

Distinguished Physician, Dr. Warren J. Bleiweiss, Fellow of the AASCP, Will Present at the AASCP Conference on June 17-19, 2022

May 1, 2022 By Cade Hildreth (CEO) 1 Comment

dr-warren-j-bleiweiss
American Academy of Stem Cell Physicians will host expert speakers from across the country lecturing on recent innovations in stem cell research on June 17-19, 2022, in Miami, Florida.

“The Academy is proud to offer state-of-the-art Regenerative Medicine workshops this June, which will be lead by experts with over 100 years of combined experience,” said Dr. Sunny Kim, President of the AASCP. [Read more…]

Filed Under: Cell Therapy, Press Releases, Stem Cell News

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 270
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

PolarityTE RMAT

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

What Is An RMAT? List of Publicly Announced RMAT Designations (64)

i-peaces-cell-manufacturing

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.